Acute myocardial infarction results in 7.2 million deaths per year world-wide.The treatment of AMI in the post-myocardial infarction period differs among the races and genders. This study investigated differences in mortality between Mexican American (MA) males and females, post-AMI who received BB therapy and those who did not receive BB therapy.Findings from this secondary analysis indicate that MA females experienced a higher mortality post-AMI compared to MA males. However, MA females taking BB therapy post-AMI had a reduced odds of mortality compared to MA males taking BB post-AMI. Interestingly, MA females were less likely to have received BB therapy post-AMI compared to MA males, despite its apparent benefit.
AMERICAN HEART ASSOCIATION. Heart Disease in women. [ Online http://www.AHA.org ], 1998.
AMERICAN HEART ASSOCIATION. International cardiovascular disease statistics. [ Online http://www.american heart.org/presenter.jhtml?identifier=3001008 ], 2003.
BABER, N. S., WAINWRIGHT, E. D., HOWITT, G., THOMAS, M., WILSON, C., & LEWIS, J. A.. Multicentre post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy and Yugoslavia. British Heart Journal, v. 44, p. 96-100, 1980
FREEMANTLE, N., CLELAND, J., YOUNG, P., MASON, J., & HARRISON, J. b-Blockade after myocardial infarction: systematic review and meta regression analysis. British Medical Journal, v. 318, n. 6, p. 1730-1737, 1999.
GANONG, W.P. Review of Medical Physiology. Hartford, CT: Prentice Hall,1999.
GOFF, D. C. JR., RAMSEY, D. J., LABARTHE, D. R., & NICHAMAN, M. Z. Acute myocardial infarction and Coronary artery disease mortality among Mexican Americans and non-MA in Texas, 1980 through 1989. Ethnicity Diseases, v. 3, n.1, p. 64-69, 1993.
ISIS-1 Collaborative Group. Randomized trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group. Lancet, v. 2, p. 57-66, 1986.
KRUMHOLZ, H. M., RADFORD, M. J., WANG, Y., CHEN, J., HEIAT, A., & MARCINIAK, T. A. Rational use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA, v. 280, n. 7, p. 623-962, 1998.
MILLER, A.C. Cardiac Physiology: Miller Anesthesia. (5th ed.).Springfield, IL: Churchill Livingstone, 2000.
NICHAMAN, M. Z., WEAR, M. L., GOFF, D. C. JR., & LABARTHE, D. R. Hospitalization rates for myocardial infarction among Mexican-Americans and non-MA. The Corpus Christi Heart Project. Annals of Epidemiology, v. 3, n. 1, p. 42-48, 1993.
NOHRIA, A., VACCARINO, V., & KRUMHOLZ, H. M. Gender differences in mortality after myocardial infarction. Why women fare worse than men. Cardiology Clinics, v. 16, n.1, p. 45-57, 1998.
THE MIAMI TRIAL RESEARCH GROUP. (1985). Metoprolol in acute myocardial infarction. Arrhythmias. The MIAMI Trial Research Group. American Journal of Cardiology, v. 56, n.14, p.35G-38G.
OLSSON, G., WIKSTRAND, I., WARNOLD, V., MANGER, C., MCBOYLE, D., HERLITZ, J., HJALMARSON, A., & SONNENBLICK, E. H. Metoprolol-induced reduction in post-infarction mortality: Pooled results from five double-blind randomized trials. The European Society of Cardiology, v. 19, n. 10, p. 28-32, 1992.
US BUREAU OF THE CENSUS. 2000 Census of the population: General population characteristics, Texas. Washington, DC: US Department of Commerce 2001.